Currently accepted at: JMIR Research Protocols
Date Submitted: Dec 27, 2024
Date Accepted: Feb 3, 2026
This paper has been accepted and is currently in production.
It will appear shortly on 10.2196/70617
The final accepted version (not copyedited yet) is in this tab.
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Status of evidence on efficacy and safety of Indian Traditional medicine (AYUSH) for Pre-diabetes and Type-II Diabetes Mellitus: Protocol for Qualitative Review & Evidence Map synthesis
ABSTRACT
Background:
Introduction: Non-communicable diseases, particularly Diabetes, are a growing global burden, with India rapidly becoming the diabetes capital of the world. Data on diabetes Awareness, treatment, and control from 20,78,315 Indians in NFHS-5 in 2023 revealed that of those with the disease, 27.5% (27.1–27.9%) were aware, 21.5% (21.1–21.7%) were receiving treatment, and only 7% (6.8–7.1%) had their diabetes under control. Over 81% of people with diabetes hail from low-and middle-income countries. With their emphasis on lifestyle management and holistic approach, traditional medical systems present a promising alternative that may help lessen the burden of diabetes through sustainable and natural methods. Traditional medicine uses many therapeutic concepts to manage diabetes, but there is no appropriate methodology to demonstrate their effectiveness.
Objective:
The aim of this study is to develop a protocol that qualitatively evaluates the status of evidence on safety and efficacy of Indian Traditional systems of Medicine (AYUSH) for the management of Pre-diabetes and Type- II Diabetes Mellitus to establish a road map of evidence through research for better outcomes in future.
Methods:
All study designs including Systematic reviews and meta-analysis, Narrative reviews, RCTs, non-randomized CTs , parallel arm intervention trials, Pre-test post-test trials, observational studies (including cross-sectional , case- control and cohort studies), case series and case reports from the first available published literature to July 2024 will be assessed. All the AYUSH interventions studied in India as Standalone or Add-on to Standard of Care for the management of Diabetes will be included in the study. The database search will be performed with all AYUSH key words related to Prediabetes and Type II Diabetes mellitus using Boolean operators. The safety and efficacy of AYUSH interventions will be evaluated based on specified Subjective and objective measures including Clinical recovery, Quality of Life, any adverse events that are specific or otherwise based on LFT, KFT, and Lipid profile etc.
Results:
protocol is developed.
Conclusions:
Large translational gaps remain despite increased awareness of the global diabetes crisis and ongoing multinational efforts to curb rising diabetes rates which makes way for the contribution of Traditional system of medicine. Though there are differences in treatment types available in India's traditional medicine systems, a protocol has been developed to effectively map the evidence for all treatments available for Type II diabetes and prediabetes in AYUSH systems of medicine. Clinical Trial: PROSPERO (International Prospective Register for Systematic Reviews) Reg. No. – CRD42024545045
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.